NuvaRing is marketed as a safe, effective, and convenient birth control method. NuvaRing is a small ring a woman inserts in her vagina once a month for three weeks to prevent pregnancy. NuvaRing is purchased with a prescription only.
The NuvaRing is a vaginal ring which works like other birth control methods by releasing hormones, estonogestrel, an artificial progestin, and ethinyl estradiol, an artificial estrogen. It is inserted one time each month but remains for three weeks before removal. The NuvaRing not only stops the release of eggs from the ovaries, but also increases the cervical mucus, which acts as a barrier to male sperm, reducing the chance that an egg will be fertilized or implanted. The NuvaRing does not, however, eliminate the menstrual cycle or protect a woman against sexually transmitted diseases.
Initially manufactured by Organon, the NuvaRing was approved for use by the United States Food and Drug Administration in the United States in 2002. It is currently manufactured by Merck & Co. The NuvaRing has been promoted more than 5.5 million times and has grown in popularity because it eliminates the need for women to remember to take birth control medication each day. It is currently used by an estimated one million women in the United States and is said to be 99% effective at reducing the risk of an unwanted pregnancy.
Despite NuvaRing’s popularity troubles with the product surfaced as early as 2008 when a New Jersey man filed the first lawsuit against Merck and Co. after his wife suffered severe seizures due to pulmonary embolism which were later attributed to use of the vaginal ring. Hundreds of personal injury lawsuits against Merck and Co. have followed.
Studies have linked the use of birth control devices which use desogestrel to a higher risk of blood clots, heart attacks, strokes, and other health problems. One of the most serious potential side-effects of using the NuvaRing are blood clots. This is especially true for women who are over the age of thirty-five, who smoke, and/or who are obese. Medical experts warn that women with a blood clot are not only more likely to suffer a heart attack or stroke, but they can also become permanently disabled. Women are at the greatest risk for blood clots from using the NuvaRing when they first start using the product.
NuvaRing lawsuits have been filed against Merck & Co. claiming they have not adequately warned users of the risks associated with using the NuvaRing. Anyone who chooses to use the NuvaRing should be under the care of their doctor and seek medical attention immediately if they develop a serious side-effects from its use.